USANA Health Sciences Beheer
Beheer criteriumcontroles 3/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Jim Brown
Algemeen directeur
US$2.5m
Totale compensatie
| Percentage CEO-salaris | 28.7% |
| Dienstverband CEO | 8yrs |
| Eigendom CEO | n/a |
| Management gemiddelde ambtstermijn | 7.8yrs |
| Gemiddelde ambtstermijn bestuur | 6.7yrs |
Recente managementupdates
Recent updates
USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital
Sep 26
Is There Now An Opportunity In USANA Health Sciences, Inc. (NYSE:USNA)?
Sep 08USANA Health Sciences, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Jul 26There Is A Reason USANA Health Sciences, Inc.'s (NYSE:USNA) Price Is Undemanding
Jul 17USANA Health Sciences (NYSE:USNA) Might Be Having Difficulty Using Its Capital Effectively
May 29USANA Health Sciences, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
May 03Is Now The Time To Look At Buying USANA Health Sciences, Inc. (NYSE:USNA)?
May 01USANA Health Sciences, Inc.'s (NYSE:USNA) Prospects Need A Boost To Lift Shares
Apr 04USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital
Feb 08Is It Too Late To Consider Buying USANA Health Sciences, Inc. (NYSE:USNA)?
Jan 06USANA: New Digital Tools And Solid Balance Sheet Imply Undervaluation
Oct 23Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 22%?
Sep 09Here's What's Concerning About USANA Health Sciences' (NYSE:USNA) Returns On Capital
Jul 27USANA Earnings Preview: From China's Challenge To India's Promise
Jul 21USANA Health Sciences says Brown will transition to CEO in July 2023
Feb 13Returns On Capital At USANA Health Sciences (NYSE:USNA) Paint A Concerning Picture
Feb 02USANA Health Sciences down 17% after revising 2022 outlook below consensus estimates
Oct 25Here's What To Make Of USANA Health Sciences' (NYSE:USNA) Decelerating Rates Of Return
Oct 18Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 26%?
Jul 22Returns On Capital At USANA Health Sciences (NYSE:USNA) Have Stalled
Jul 07Is USANA Health Sciences (NYSE:USNA) Using Too Much Debt?
Jun 14Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Sep 28 2024 | n/a | n/a | US$54m |
| Jun 29 2024 | n/a | n/a | US$55m |
| Mar 30 2024 | n/a | n/a | US$62m |
| Dec 30 2023 | US$2m | US$710k | US$64m |
| Sep 30 2023 | n/a | n/a | US$60m |
| Jul 01 2023 | n/a | n/a | US$63m |
| Apr 01 2023 | n/a | n/a | US$65m |
| Dec 31 2022 | US$2m | US$624k | US$69m |
| Oct 01 2022 | n/a | n/a | US$77m |
| Jul 02 2022 | n/a | n/a | US$89m |
| Apr 02 2022 | n/a | n/a | US$108m |
| Jan 01 2022 | US$2m | US$600k | US$117m |
| Oct 02 2021 | n/a | n/a | US$136m |
| Jul 03 2021 | n/a | n/a | US$139m |
| Apr 03 2021 | n/a | n/a | US$129m |
| Jan 02 2021 | US$2m | US$599k | US$125m |
| Sep 26 2020 | n/a | n/a | US$116m |
| Jun 27 2020 | n/a | n/a | US$110m |
| Mar 28 2020 | n/a | n/a | US$103m |
| Dec 28 2019 | US$2m | US$559k | US$101m |
| Sep 28 2019 | n/a | n/a | US$102m |
| Jun 29 2019 | n/a | n/a | US$109m |
| Mar 30 2019 | n/a | n/a | US$121m |
| Dec 29 2018 | US$2m | US$534k | US$126m |
| Sep 29 2018 | n/a | n/a | US$88m |
| Jun 30 2018 | n/a | n/a | US$81m |
| Mar 31 2018 | n/a | n/a | US$70m |
| Dec 30 2017 | US$1m | US$523k | US$63m |
Compensatie versus markt: De totale vergoeding ($USD 2.47M ) Jim } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 3.23M ).
Compensatie versus inkomsten: De beloning van Jim is het afgelopen jaar met meer dan 20% gestegen, terwijl de winst van het bedrijf met meer dan 20% is gedaald.
CEO
Jim Brown (55 yo)
8yrs
Tenure
US$2,472,017
Compensatie
Mr. Jim Brown has been the President of USANA Health Sciences Inc. since November 2016 and served as its Chief Operating Officer since November 2013 until October 2019. He serves as Chief Executive Officer...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Executive Chairman | 7.5yrs | US$3.91m | 0.064% $ 454.1k | |
| CEO & President | 8yrs | US$2.47m | geen gegevens | |
| Chief Financial Officer | 7.5yrs | US$1.47m | 0% $ 0 | |
| Chief Operating Officer | 5.1yrs | US$1.42m | geen gegevens | |
| Chief Legal Officer | 6.3yrs | US$1.29m | geen gegevens | |
| Chief Communications & Marketing Officer | 12.9yrs | US$1.15m | 0% $ 0 | |
| Founder & Chairman Emeritus | 32.8yrs | geen gegevens | 41.28% $ 293.3m | |
| Executive Director of Product Development & Technology | 11.9yrs | geen gegevens | geen gegevens | |
| Chief Scientific Officer | 8.3yrs | geen gegevens | geen gegevens | |
| Chief Information Officer | no data | geen gegevens | geen gegevens | |
| Executive Director of Investor Relations & Business Development | no data | geen gegevens | geen gegevens | |
| Chief People Officer | 3.8yrs | US$637.78k | 0% $ 0 |
7.8yrs
Gemiddelde duur
58yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van USNA is doorgewinterd en ervaren (gemiddelde ambtstermijn van 7.8 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Executive Chairman | 7.5yrs | US$3.91m | 0.064% $ 454.1k | |
| Founder & Chairman Emeritus | 4.5yrs | geen gegevens | 41.28% $ 293.3m | |
| Lead Independent Director | 16.2yrs | US$251.60k | 0% $ 0 | |
| Independent Director | 5.9yrs | US$231.40k | 0.019% $ 135.6k | |
| Independent Director | 5.1yrs | US$218.40k | 0.031% $ 221.0k | |
| Member of Scientific Advisory Council | no data | geen gegevens | geen gegevens | |
| Member of Scientific Advisory Council | no data | geen gegevens | geen gegevens | |
| Chairperson of Scientific Advisory Council | 20.8yrs | geen gegevens | geen gegevens | |
| Member of Scientific Advisory Council | no data | geen gegevens | geen gegevens | |
| Member of Scientific Advisory Council | no data | geen gegevens | geen gegevens | |
| Independent Director | 8.5yrs | US$233.60k | 0.020% $ 143.5k | |
| Independent Director | 2.3yrs | US$218.40k | 0.019% $ 132.8k |
6.7yrs
Gemiddelde duur
68yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van USNA wordt beschouwd als ervaren (gemiddelde ambtstermijn 6.7 jaar).